The dry antibiotic development pipeline coupled with the emergence of multidrug resistant Gram-negative ‘superbugs’ has driven the revival of the polymyxin lipopeptide antibiotics. Polymyxin resistance implies a total lack of antibiotics for the treatment of life-threatening infections. The lack of molecular imaging probes that possess native polymyxin-like antibacterial activity is a barrier to understanding the resistance mechanisms and the development of a new generation of polymyxin lipopeptides. Here we report the regioselective modification of the polymyxin B core scaffold at the <i>N</i>-terminus with the dansyl fluorophore to generate an active probe that mimics polymyxin B pharmacologically. Time-lapse laser scanning confocal micro...
Polymyxins are last-resort antibiotics with potent activity against multi-drug resistant pathogens. ...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Antibiotic resistance is a major public health challenge, and Gram-negative multidrug-resistant bact...
Resistance to all known antibiotics is a growing concern worldwide, and has renewed the interest in ...
Antibiotic resistance is a major public health challenge, and Gram-negative multidrug-resistant bact...
Most Gram-negative bacteria are susceptible to polymyxin B (PxB), and development of resistance to t...
The antimicrobial lipopeptides polymyxin B and E (colistin) are being used as a 'last-line' therapy ...
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/46988Membrane-active antimicrobial p...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/46988Membrane-active antimicrobial p...
Polymyxins are last-resort antibiotics with potent activity against multi-drug resistant pathogens. ...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Polymyxins (polymyxin B and colistin) are cyclic lipopeptide antibiotics that serve as a last-line d...
Antibiotic resistance is a major public health challenge, and Gram-negative multidrug-resistant bact...
Resistance to all known antibiotics is a growing concern worldwide, and has renewed the interest in ...
Antibiotic resistance is a major public health challenge, and Gram-negative multidrug-resistant bact...
Most Gram-negative bacteria are susceptible to polymyxin B (PxB), and development of resistance to t...
The antimicrobial lipopeptides polymyxin B and E (colistin) are being used as a 'last-line' therapy ...
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/46988Membrane-active antimicrobial p...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/46988Membrane-active antimicrobial p...
Polymyxins are last-resort antibiotics with potent activity against multi-drug resistant pathogens. ...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...